Skip to content

Clinical trials

Inflammation trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Country / region: China Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20093
20112
20124
20138
201410
20151
20164
20178
20182
20191
202011
202110
20227
20238
202414
202514
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Unknown status37
Recruiting23
Not yet recruiting5
Withdrawn3
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital7
Fudan University6
Guangzhou Institute of Respiratory Disease4
Nanjing Medical University4
Second Affiliated Hospital, Zhejiang University, School of Medicine4
Central South University3
Beijing Anzhen Hospital2
Huashan Hospital2
Ocumension Therapeutics (Shanghai) Co., Ltd2
Peking University First Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation111
Coronary Artery Disease7
Sepsis6
Non-alcoholic Fatty Liver Disease4
Obesity4
Thrombosis4
Aortic Dissection3
Atherosclerosis3
Cardiovascular Diseases3
Cognitive Dysfunction3

Trials

Showing 51 to 75 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.